Work

A pilot phase 2 study of ruxolitinib for the treatment of steroid-refractory hypereosinophilic syndrome

Year: 2024

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2023.11.221

Authors: Charles Anderson, Paneez Khoury, Michelle Makiya, Xiaoping Sun, Irina Maric, Amy Klion

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institutes of Health Clinical Center

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391534934

FWCI: 0.277

Cites:

Cited by: 1

Related to: 10